EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--March 9, 2005--SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and drug delivery technologies to the medical device industry, today announced that it will make a presentation to the investment community at the Goldman Sachs Small Cap Growth Conference.

Phil Ankeny, Chief Financial Officer and Vice President, Business Development, is scheduled to present an overview of the Company and its growth strategies on Friday, March 11 at 10:30 a.m. (ET). The conference runs March 10 and 11 in New York and features approximately 40 presenting companies.

A link to a Webcast of the presentation will be available in the investor relations section of SurModics' web site at www.surmodics.com. Investors are advised to visit the site at least 10 minutes before the scheduled presentation to register, download and install any necessary multimedia streaming software. The software plug-ins required for the live event can be either RealPlayer or Windows Media Player. This audio file of this webcast will be archived and available on the Company's site for 30 days.

About SurModics, Inc.

SurModics, Inc., a leading provider of surface modification and drug delivery solutions, licenses its proprietary technologies to medical device, diagnostics, and biotechnology companies around the world. A significant portion of SurModics' revenue is generated through royalties on the sale of coated products. SurModics' Internet address is www.surmodics.com.

CONTACT: SurModics, Inc., Eden Prairie
Phil Ankeny, 952-829-2700

SOURCE: SurModics, Inc.